share_log

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

HC Wainwright & Co.重申買入Amylyx Pharma,維持8美元的目標股價
Moomoo 24/7 ·  04/11 06:29

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

HC Wainwright & Co. 分析師安德魯·費恩重申Amylyx Pharma(納斯達克股票代碼:AMLX)的買入並維持8美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論